Idiopathic Short Stature
31
7
7
17
Key Insights
Highlights
Success Rate
85% trial completion
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 29/100
9.7%
3 terminated out of 31 trials
85.0%
-1.5% vs benchmark
42%
13 trials in Phase 3/4
41%
7 of 17 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 17 completed trials
Clinical Trials (31)
Multidisciplinary Evaluation and a Genome-wide Analysis in a Cohort of Idiopathic Short Stature Patients
Trial Investigating the Efficacy and Safety of Weekly Lonapegsomatropin Compared to Daily Somatropin in Children and Adolescents With Short Stature or Growth Failure Due to Growth Hormone Sufficient Disorders
A Phase 2 Study of Vosoritide in Children With Idiopathic Short Stature
The Efficacy and Safety of Inpegsomatropin Injection in Children With Idiopathic Short Stature
A Study (Phase 1b/2) of GenSci134 in Children With Idiopathic Short Stature (ISS)
A Study of the Genetic Basis of Response to Growth Hormone Treatment in Children With Idiopathic Short Stature
A Study to Assess Growth in Children With Idiopathic Short Stature
Skeletal Muscle Effects of GH in Boys
A Trial of YPEG-rhGH in Children With Short Stature
A 4 Year Combination Therapy of Growth Hormone and (GnRH) Agonist in Children With a Short Predicted Height
Long-term Safety and Effectiveness of Growtropin®-II Treatment in Children With Short Stature
The Impact of the Use of Recombinant Human Growth Hormone on ADHD Characteristics in Children and Adolescents
Long-term Safety and Effectiveness of Growth Hormone With GHD, TS, CRF, SGA , ISS and PWS in Children
Growth Response in Short Children Suffering From a Disease With Growth Retardation and Treated With Somatropin
Predictive Value of the Insulin-like Growth Factor-1 (IGF-1) Generation Test for the Growth Response to Growth Hormone Treatment (PRED-IGF)
Epidemiology Study on Insulin-like Growth Factor-1 in Children With Idiopathic Short Stature (EPIGROW Study)
Aromatase Inhibitors, Alone And In Combination With Growth Hormone In Adolescent Boys With Idiopathic Short Stature
Short Stature Related Distress
Efficacy and Safety of DA-3002 in Children With Idiopathic Short Stature
Efficacy and Safety of Recombinant Human Growth Hormone on Height Velocity in Subjects With Idiopathic Short Stature